Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.695 USD | -3.53% | -13.35% | +33.76% |
Financials (USD)
Sales 2024 * | 108M | Sales 2025 * | 277M | Capitalization | 4.8B |
---|---|---|---|---|---|
Net income 2024 * | -437M | Net income 2025 * | -307M | EV / Sales 2024 * | 44.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 17.3 x |
P/E ratio 2024 * |
-8.26
x | P/E ratio 2025 * |
-13.7
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 22.2% |
Latest transcript on ImmunityBio, Inc.
1 day | -2.23% | ||
1 week | -12.65% | ||
Current month | -15.27% | ||
1 month | +23.32% | ||
3 months | +93.43% | ||
6 months | +64.32% | ||
Current year | +34.86% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 1,487 M€ | +8.98% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 6.705 | -3.39% | 1 203 512 |
24-05-22 | 6.94 | +1.98% | 4,136,143 |
24-05-21 | 6.805 | -3.34% | 4,884,878 |
24-05-20 | 7.04 | -7.97% | 7,273,974 |
24-05-17 | 7.65 | -1.29% | 4,923,091 |
Delayed Quote Nasdaq, May 23, 2024 at 10:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.86% | 4.8B | |
+10.57% | 115B | |
+12.40% | 106B | |
-5.38% | 24.69B | |
-1.22% | 21.97B | |
-4.87% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.95% | 14.03B | |
+33.62% | 12.13B |
- Stock Market
- Equities
- IBRX Stock